Status:
COMPLETED
Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children
Lead Sponsor:
Sanofi Pasteur, a Sanofi Company
Conditions:
Dengue
Dengue Fever
Eligibility:
All Genders
5-10 years
Brief Summary
This is a descriptive prospective community-based seroprevalence study. Primary objective: * To determine the prevalence of specific antibodies (immunoglobulin G \[IgG\]) against dengue in healthy 5...
Eligibility Criteria
Inclusion
- Aged between 5 and 10 year-old on the day of inclusion
- Healthy child as reported by the parent or legally qualified guardian
- Being registered in selected study site
- Provision of the informed consent form signed by at least one parent or legally qualified guardian
- For children between 8 and 10 years old, provision of the assent form signed.
Exclusion
- N/A
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
667 Patients enrolled
Trial Details
Trial ID
NCT01477671
Start Date
September 1 2011
End Date
December 1 2013
Last Update
January 11 2018
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Kalyani, West Bengali, India, 741235
2
Bangalore, India, 560070
3
Hyderabad, India, 500063
4
New Delhi, India, 110002